Source: Annual Congress 2011 - Cell biology of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kratzer, J. Salys, H. W. Chu, M. Zamora, L. Taraseviciene-Stewart (Denver, United States Of America). CD146 in the pathogenesis of COPD. Eur Respir J 2011; 38: Suppl. 55, 3892

Member's Comments

No comment yet.

Related content which might interest you: The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 PARK2-regulated mitophagy in COPD pathogenesis Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 DPP10 protein expression is associated with the pathogenesis of asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 231s Year: 2005 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function Source: Eur Respir J 2006; 28: 113-122 Year: 2006 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Expression of CD38 and its participation in formation of endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Circulating adhesion molecules in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 321s Year: 2004 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 3-5 Year: 2004 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012